Doxycycline Hyclate Capsule
FDA Label NDC 60687-513

30 label sections · Submitted to the FDA by American Health Packaging · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by American Health Packaging for the product Doxycycline Hyclate (NDC 60687-513). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, clinical pharmacology, microbiology, susceptibility testing, indications and usage, treatment, prophylaxis, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Packaging Information

American Health Packaging unit dose blisters (see How Supplied section) contain drug product from Hikma Pharmaceuticals USA Inc. as follows:
(100 mg / 50 UD) NDC 60687-513-65 packaged from NDC 0143-9803

Distributed by:
American Health Packaging
Columbus, OH 43217

8451321/0124

Package/Label Display Panel – Carton – 100 Mg

NDC 60687- 513-65

Doxycycline Hyclate
Capsules, USP

100 mg*

50 Capsules (5 x 10)                Rx Only

*Each Capsule Contains:
Doxycycline Hyclate, USP equivalent to 100 mg of Doxycycline, USP.

USUAL ADULT DOSAGE: See full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

Protect from light and moisture.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 0143-9803, Hikma Pharmaceuticals USA Inc.

Distributed by: American Health Packaging, Columbus, Ohio 43217

753165
0451365/0124

Package/Label Display Panel – Blister – 100 Mg

Doxycycline
Hyclate
Capsule, USP

100 mg

* Please review the disclaimer below.